Stocks and Investing Stocks and Investing
Thu, February 29, 2024

Corinne Jenkins Maintained (TGTX) at Hold with Increased Target to $13 on, Feb 29th, 2024


Published on 2024-10-28 09:18:18 - WOPRAI, Corinne Jenkins
  Print publication without navigation


Corinne Jenkins of Goldman Sachs, Maintained "TG Therapeutics, Inc." (TGTX) at Hold with Increased Target from $12 to $13 on, Feb 29th, 2024.

Corinne has made no other calls on TGTX in the last 4 months.



There are 4 other peers that have a rating on TGTX. Out of the 4 peers that are also analyzing TGTX, 0 agree with Corinne's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Corinne


  • Edward White of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $45 on, Wednesday, February 28th, 2024
  • Mayank Mamtani of "B. Riley Securities" Maintained at Strong Buy with Increased Target to $29 on, Monday, February 5th, 2024
  • Eric Joseph of "JP Morgan" Maintained at Buy with Increased Target to $23 on, Wednesday, November 1st, 2023
  • Matthew Andrews of "Jefferies" Maintained at Strong Buy on, Wednesday, November 1st, 2023
Contributing Sources